Abstract
When the disease state improves during penicillamine therapy, resumption of growth occurs; if activity persists despite therapy, the expected fall-off in growth due to active Still's disease continues. Penicillamine does not interfere with the growth spurt after withdrawal of corticosteroid therapy or with the maintained slow growth during alternate-day steroid therapy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANSELL B. M., BYWATERS E. G. Growth in Still's disease. Ann Rheum Dis. 1956 Dec;15(4):295–319. doi: 10.1136/ard.15.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ansell B. M. Problems of corticosteroid therapy in the young. Proc R Soc Med. 1968 Mar;61(3):281–282. doi: 10.1177/003591576806100333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bourke B., Maini R. N., Griffits I. D., Scott J. T. Fatal marrow aplasia in patient on penicillamine. Lancet. 1976 Sep 4;1(7984):515–515. doi: 10.1016/s0140-6736(76)90804-7. [DOI] [PubMed] [Google Scholar]